Bocxman,
You just posted, "Everyone can read the 10-k's, P.R's, charts, etc. There is no edge there whatsoever."
Weren’t you recently giving this board an almost daily technical analysis of Biocurex’s chart? Only a true novice would get involved with the technical analysis of an illiquid stock like BioCurex. It is a bit embarrassing for the pot to be calling the kettle black, isn't it?
And did you miss the edge that was quite apparent from the last two press releases? Sorry, you won't get that edge by taking to anyone at BioCurex. kag
